Atrial Fibrillation Trial, Recruiting NCT07726056 Sponsor: University Hospital of Leuven Leuven Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07726056
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 80 years old
  • People who participate in endurance sports for at least 4 hours per week
  • People who have been diagnosed with atrial fibrillation (an irregular heart rhythm condition)
  • People who already record their training activity using platforms such as Strava or TrainingPeaks, or who are willing to start doing so during the trial

Who may not be able to join:

  • People for whom no training data is available
  • People with a history of certain heart conditions, including blocked arteries in the heart, heart muscle disease, heart valve disease, inherited heart rhythm disorders, or heart failure
  • People who currently smoke

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Guido Claessen, MD, PhD, University of Hasselt, LCRC

Phone: +32477399875

Australian sites

St. Vincent's Hospital, Melbourne,
+61 3 9231 2211

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital of Leuven Leuven
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
31 December 2030

Where this trial is recruiting

🇦🇺 Australia 🇧🇪 Belgium

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Change in peak VO2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov